Alzheimer's Light-Sound Headset Trial Shows Mixed Efficacy Results
Published 2 d ago1 sourceEvidence: Unknown
A Liège-developed implant is being tested in the ONFIELD pilot study, the first human trial of this technology, targeting cluster headache patients unresponsive to existing treatments. Initial observations indicate reduced attack frequency with no serious adverse events reported, though the study is early-stage and small-scale. This matters as cluster headache is among the most severe pain conditions, and a viable neuromodulation option would fill a significant treatment gap.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Locations
Published 2 d ago1 sourceEvidence: Unknown
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 11 h ago1 sourceEvidence: Reported
Published 20 h ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 19 h ago1 sourceEvidence: Reported